Related Experiment Video
Updated: May 4, 2026
12:21
MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
14.2K
Uroplakin II outperforms uroplakin III in diagnostically challenging settings
Steven C Smith1, Sambit K Mohanty, Lakshmi P Kunju
1Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Histopathology
|January 3, 2014
Summary
A new uroplakin II (UP2) antibody demonstrates superior performance compared to the uroplakin III (UP3) antibody for diagnosing urothelial carcinoma (UC). UP2 shows higher sensitivity and intensity in challenging cases, making it a valuable biomarker for UC detection.
Area of Science:
- Urothelial Carcinoma Biomarkers
- Immunohistochemistry
- Cancer Diagnostics
Background:
- Uroplakin III (UP3) antibodies are established biomarkers for urothelial carcinoma (UC).
- A novel antibody targeting uroplakin II (UP2) has been developed.
- The diagnostic utility of UP2 in challenging settings requires evaluation.
Purpose of the Study:
- To conduct a head-to-head comparison of UP3 and UP2 antibodies.
- To assess the performance of UP2 in diagnostically challenging urothelial carcinoma cases.
Main Methods:
- Immunohistochemical staining for UP3 and UP2 was performed on high-grade bladder neck carcinomas, upper tract urothelial carcinomas, renal carcinomas, and UC metastases.
- Staining intensity and proportion were scored.
- Sensitivity and specificity were evaluated for UC detection.
Main Results:
- UP2 staining exhibited greater intensity and proportion than UP3 in bladder neck lesions, upper tract UC, and UC metastases.
- UP2 demonstrated significantly higher sensitivity for UC detection across all tested groups compared to UP3.
- Both antibodies showed high specificity, with UP2 performing comparably to UP3 in differentiating UC from other cancers.
Conclusions:
- The UP2 antibody significantly outperforms the UP3 antibody in sensitivity and staining intensity for urothelial carcinoma.
- UP2 is a valuable and effective addition to the biomarker panel for UC diagnosis, particularly in difficult cases.
- No non-urothelial tumors stained positive for either UP3 or UP2, confirming their specificity.
Related Concept Videos
01:22Imaging Studies V: Intravenous Urography and Retrograde Pyelography
3.5K
IntroductionIntravenous Urography (IVU) and Retrograde Pyelography (RP) are important diagnostic imaging techniques used to evaluate the urinary system. These methods help identify structural abnormalities, obstructions, and functional issues in the kidneys, ureters, and bladder. Both procedures use iodine-based contrast media to enhance the visibility of urinary tract structures on X-ray images, though they differ in their methods and indications.1. Intravenous Urography (IVU)Intravenous...
3.5K
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
434
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
434
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
1.0K
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
1.0K
01:24Imaging Studies II: Ultrasonography
909
IntroductionUltrasonography, or renal ultrasound, is a noninvasive medical imaging technique that uses high-frequency sound waves to visualize the kidneys, ureters, bladder, and surrounding tissues.Indications for Urinary System UltrasonographyUrinary system ultrasonography is indicated in various clinical scenarios, such as:Kidney Stones (Urolithiasis): To detect and monitor the size and presence of kidney or urinary tract stones.Hydronephrosis: To assess the dilation of the renal pelvis and...
909
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
842
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
842
01:28Imaging Studies I: Kidney, Ureter, and Bladder Studies
871
Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...
871